Company Directory / research

PrivateFor profitresearchSingapore, Singapore
Nuevocor operates as a preclinical-stage biotech company.
Size
11-50 people: larger than 33% of companies with a size listed
Age
6 years old.
Reach
No web traffic ranking listed.
BiopharmaBiotechnologyMedicalPharmaceutical
Funding, as listed
$45M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Nuevocor, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Nuevocor may be growing as it has received research funding, which is a positive indicator of financial support and investment in its preclinical biotech activities. The financial backing is crucial for the company's research and development efforts, which are essential in the biopharma and biotechnology industries. Additionally, the mention of consulting fees suggests that Nuevocor is engaged in professional services, which may contribute to its revenue streams and indicate a level of expertise and recognition in the field.
Summaries written by the source dataset, not by us, and not checked.
research in Singapore.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 17,167 companies in Singapore and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.